Lifeward (NASDAQ: LFWD) is scheduled to release its fourth-quarter earnings for 2025 before the market opens on March 6, 2026. Analysts predict the company will report a loss of $0.07 per share and generate revenue of approximately $7.87 million for the quarter. Interested parties can find additional details on the company’s earnings summary page ahead of the conference call set for March 13, 2026, at 10:30 AM ET.
Investors are closely watching Lifeward’s stock performance as shares opened at $5.99 on Thursday. The company currently boasts a market capitalization of $9.10 million, a price-to-earnings ratio of -0.17, and a beta of 0.12. Lifeward’s stock has experienced significant fluctuations, with a one-year low of $4.14 and a high of $35.40. The 50-day simple moving average stands at $7.08, while the 200-day simple moving average is $7.47.
Recent activity among institutional investors reflects growing interest in Lifeward’s stock. Notably, Citadel Advisors LLC significantly increased its stake by 1,271.8% during the third quarter, acquiring an additional 198,406 shares to own a total of 214,006 shares valued at $152,000. Similarly, HRT Financial LP raised its position by 149.7% in the fourth quarter, obtaining 29,423 shares to hold 49,081 shares worth $28,000.
Other significant institutional moves include Jane Street Group LLC, which raised its position by 77.3% during the fourth quarter, and Virtu Financial LLC, which increased its stake by 158.0%. Collectively, institutional investors now own approximately 26.76% of Lifeward’s stock.
Lifeward specializes in rehabilitation technologies, targeting individuals with physical and neurological conditions. The company, previously known as ReWalk Robotics Ltd., develops and commercializes products such as the personal exoskeleton and rehabilitation devices, aimed at enhancing mobility and wellness. Their offerings include the ReStore soft exo-suit for stroke rehabilitation, the AlterG Anti-Gravity System for physical and neurological rehabilitation, and the MyoCycle devices, among others.
As Lifeward prepares for its upcoming earnings announcement, investors remain alert to the potential implications of these results on the company’s future trajectory and market position.
